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PROJECT SUMMARY
NASA has developed computationally intensive tools which can be used for medical
classification problems. These tools include recursive partitioning (also called CART) and
artificial neural networks. However, most medical decision making problems are not those
of classification but those which contain time-until-event (also called survival) data. The
challenges are (1) how to extend these computational tools to survival-type data, (2) how to
tell when the computationally-intensive tool will perform better than a standard statistical
method, and (3) to test these tools on a clinically challenging problem, the prognosis of
patients with clinically localized prostate cancer who are treated with surgery.
In the beginning of this project, work was directed at the methodology for extending
these tools to the context of survival data. We did this by extending some of the previous
work by others who have developed a similar tool. We tested our extensions and found that
the were feasible.
With the tools in place, we began to experiment with performance issues.
Theoretically these tools overcome limitations of the traditional survival technique, the Cox
proportional hazards regression model. Experiments were designed to test whether the new
tools would, in practice, overcome these limitations. Two datasets were selected where
theory suggests CART and the neural network should outperform the Cox model. The first
was a published leukemia dataset manipulated to have a strong interaction that CART should
detect. The second was a published cirrhosis dataset with pronounced nonlinear effects that a
neural network should fit. Repeated sampling of 50 training and testing subsets were
supplied to each technique. The concordance index C was calculated as a measure of
predictive accuracy by each technique on the testing dataset. In the interaction dataset,
CART outperformed Cox (19<0.05) with a C improvement of 0.1 (95% CI: 0.08 to 0.12). In
thenonlineardataset,theneuralnetworkoutperformedtheCoxmodel(p<0.05)butby avery
slightamount(0.015).Aspredictedbytheory,CARTandtheneuralnetworkwereableto
overcomelimitationsof theCoxmodel. Experimentslike theseareimportanto increaseour
understandingof whenoneof thesenewtechniqueswill outperformthestandardCoxmodel.
Furtherresearchis necessarytopredictwhichtechniquewill dobesta priori and to assess
the magnitude of superiority.
Prediction of treatment efficacy for prostate cancer therapies has proven difficult and
requires modeling of survival-type data. One reason for the difficulty may be infrequent use
of flexible modeling techniques, such as artificial neural networks. The purpose of this part
of the project was to illustrate the use of an artificial neural network to model prostate cancer
survival data and compare the neural network to the traditional statistical method, Cox
proportional hazards regression.
Clinical data and disease follow-up for 983 men were modeled by both an ANN and a
Cox model. Repeated sampling of 200 training and testing subsets were supplied to each
technique. The concordance index was calculated for each testing dataset. As further
validation, neural network and Cox models were applied to a totally separate dataset.
The neural network outperformed the Cox model in the 200-fold cross-validation
(neural network c=0.76, Cox c=0.74) and on the validation dataset (neural network c=0.77,
Cox c=0.74). Neural networks were more discriminating than Cox models for predicting
cancer recurrence. Calibration of the neural network remains a problem. Once solved, it is
expected that a neural network will make the most accurate predictions of prostate cancer
recurrence and improve treatment decision making.
